Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis

[1]  D. Valla,et al.  Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study , 2020, Advances in Therapy.

[2]  T. Luo,et al.  Measurement of Exhaled Nitric Oxide in Cirrhotic Patients with Esophageal and Gastric Varices , 2019, BioMed research international.

[3]  F. Tacke,et al.  Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence , 2019, Therapeutic advances in chronic disease.

[4]  M. Murad,et al.  Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta‐analysis , 2019, Hepatology.

[5]  D. Valla,et al.  Nonselective beta‐blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study , 2019, Alimentary pharmacology & therapeutics.

[6]  C. Crawford,et al.  Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort , 2018, Journal of gastroenterology and hepatology.

[7]  M. Senzolo,et al.  Mortality in liver transplant recipients with portal vein thrombosis – an updated meta‐analysis , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  C. Schiavone,et al.  Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers , 2018, Medical Principles and Practice.

[9]  J. Trebicka,et al.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.

[10]  J. Stine,et al.  Tu1565 - Nonselective Beta-Blockers are Associated with an Increased Risk of Portal Vein Thrombosis in Adults with Cirrhosis: A Case Control Study , 2018 .

[11]  C. Crawford,et al.  Su1560 - Trends in the Prevalence of Portal Vein Thrombosis and Associated Mortality in Cirrhosis: Analysis of a Nationally Representative Inpatient Cohort , 2018 .

[12]  S. Caldwell,et al.  Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case‐control study , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[13]  I. de Sio,et al.  The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients , 2018, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[14]  B. Sharma,et al.  Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta‐analysis , 2017, Hepatology.

[15]  A. Farcomeni,et al.  Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. , 2017, Gastroenterology.

[16]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[17]  A. Farcomeni,et al.  Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry , 2016, Internal and Emergency Medicine.

[18]  X. Qi,et al.  Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature. , 2015, Clinics and research in hepatology and gastroenterology.

[19]  R. Franchis.  Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension , 2015 .

[20]  G. Han,et al.  Novel insights into the development of portal vein thrombosis in cirrhosis patients , 2015, Expert review of gastroenterology & hepatology.

[21]  Shuofei Yang,et al.  Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension. , 2015, Journal of vascular and interventional radiology : JVIR.

[22]  W. Shou,et al.  Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis , 2015, European journal of gastroenterology & hepatology.

[23]  A. Tawfik,et al.  De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system , 2015, European journal of gastroenterology & hepatology.

[24]  P. Kamath,et al.  Mo1893 Non-Selective β Blockers Are Strongly Associated With a Decreased Risk of Portal Vein Thrombosis in Patients With Cirrhosis , 2015 .

[25]  S. Chevret,et al.  Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal study , 2015, Hepatology.

[26]  X. Qi,et al.  Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis. , 2014, World journal of gastroenterology.

[27]  D. Fan,et al.  Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis , 2014, Gastroenterology research and practice.

[28]  D. Fan,et al.  Management of portal vein thrombosis in liver cirrhosis , 2014, Nature Reviews Gastroenterology &Hepatology.

[29]  M. Poca,et al.  Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[30]  X. Qi,et al.  A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors , 2014, The Indian journal of medical research.

[31]  F. Iannuzzi,et al.  Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[32]  D. Valla,et al.  Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. , 2012, Gastroenterology.

[33]  T. Wen,et al.  Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. , 2012, World journal of gastroenterology.

[34]  C. Zhang,et al.  Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. , 2011, Medical hypotheses.

[35]  A. Cortese,et al.  180 CLINICAL AND GENETIC FACTORS ASSOCIATED TO DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS WITHOUT HEPATOCELLULAR CARCINOMA , 2011 .

[36]  A. Gasbarrini,et al.  Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. , 2009, Journal of hepatology.

[37]  J. Molnar,et al.  Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized, controlled trials. , 2009, Gastrointestinal endoscopy.

[38]  T. Wen,et al.  [Portal vein flow rate used as a early predictor of portal vein thrombosis after periesophagastric devascularization]. , 2009, Zhonghua wai ke za zhi [Chinese journal of surgery].

[39]  Wen-Yuan Guo,et al.  Liver transplant recipients with portal vein thrombosis: a single center retrospective study. , 2009, Hepatobiliary & pancreatic diseases international : HBPD INT.

[40]  Julian P T Higgins,et al.  Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales , 2008, Statistics in medicine.

[41]  D. H. Park,et al.  Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity , 2003, Journal of Gastroenterology.

[42]  J. García‐Pagán,et al.  Carvedilol, a new nonselective beta‐blocker with intrinsic anti‐alpha1‐adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis , 1999, Hepatology.

[43]  J. Calleja,et al.  Accuracy of portal and forearm blood flow measurements in the assessment of the portal pressure response to propranolol. , 1997, Journal of hepatology.

[44]  P. Hayes,et al.  Acute haemodynamic changes after oral carvedilol, a vasolidating beta-blocker, in patients with cirrhosis , 1996 .

[45]  R. Romagnoli,et al.  Effects of propranolol compared with clonidine on portal haemodynamics: a double-blind cross-over study using duplex-Doppler ultrasonography. , 1995, European journal of gastroenterology & hepatology.

[46]  R. Romagnoli,et al.  Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide‐5‐mononitrate on portal hemodynamics , 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[47]  R. Romagnoli,et al.  Duplex‐Doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs , 1992, Journal of gastroenterology and hepatology.

[48]  A. Bilić,et al.  The Effects of Selective and Non-Selective Adrenoceptor Blockade on the Portal Blood Flow in Patients with Liver Cirrhosis , 1991 .

[49]  G. Marchesini,et al.  Portal venous flow in response to acute β‐blocker and vasodilatatory treatment in patients with liver cirrhosis , 1986 .

[50]  A. Gimson,et al.  Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. , 1984, Gut.

[51]  Qiang Zhu,et al.  The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B. , 2018, Thrombosis research.

[52]  D. Fan,et al.  Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. , 2015, European journal of internal medicine.

[53]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[54]  G. Marchesini,et al.  Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. , 1993, Journal of hepatology.

[55]  G. Marchesini,et al.  Portal blood velocity and flow in aging man. , 1989, Gerontology.